Additional file 7: of Dysregulation and prognostic potential of 5-methylcytosine (5mC), 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC) levels in prostate cancer

Table S1A. Clinical characteristics for PC patients represented on the TMA. Data for RP patients for whom a 5mC score could be evaluated in malignant cores. Two PC specimens had unknown ERG status. (DOCX 15 kb)